Valenta Pharm JSC
Valenta Pharm JSC
Explore linked clinical trials.12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers | Digestive System Diseases, bile duct disorder, biliary dyskinesia, biliary tract disorder, common bile duct disorder | Recruiting | Phase 1 | 2026-06-15 | NCT07594977 | |
| Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions. | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 1 | 2026-06-12 | NCT07645534 | |
| Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia | Digestive System Diseases, bile duct disorder, biliary dyskinesia, biliary tract disorder, common bile duct disorder | Recruiting | Phase 3 | 2026-05-19 | NCT07595003 | |
| Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers. | Deglutition Disorders, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, bile duct disorder, biliary dyskinesia, biliary tract disorder, cholelithiasis, colonic disorder, common bile duct disorder, digestive system disorder, dyskinesia of esophagus, esophageal disorder, functional colonic disease, gastroesophageal reflux disease, intestinal disorder, irritable bowel syndrome, postcholecystectomy syndrome | Recruiting | Phase 1 | 2026-02-19 | NCT07421011 | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections. | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 2 | 2026-02-19 | NCT07420985 | |
| Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia | Digestive System Diseases, bile duct disorder, biliary dyskinesia, biliary tract disorder, common bile duct disorder | Recruiting | Phase 2 | 2025-07-11 | NCT06842966 | |
| Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy Volunteers | Infections, Pharyngeal Diseases, Stomatognathic Diseases, otorhinolaryngologic disease, pharyngitis, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 1 | 2025-07-10 | NCT06859281 | |
| Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers | Infections, Pharyngeal Diseases, Stomatognathic Diseases, otorhinolaryngologic disease, pharyngitis, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 1 | 2025-07-10 | NCT06857890 | |
| Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges | Infections, Pharyngeal Diseases, Stomatognathic Diseases, nasopharyngeal disorder, nasopharyngitis, otorhinolaryngologic disease, pharyngitis, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 2 | 2025-07-10 | NCT06843018 | |
| Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 1 | 2025-07-08 | NCT06859333 | |
| Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders | Neurasthenia, acute stress disorder, adjustment disorder, anxiety, anxiety disorder, psychiatric disorder, somatoform disorder | Recruiting | Phase 4 | 2025-07-08 | NCT06843044 | |
| Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo | Ear Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Vertigo, autonomic nervous system disorder, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, primary dysautonomia, vestibular disorder | Recruiting | Phase 4 | 2025-06-15 | NCT06321341 |